JP2018008882A - 生体応答性物質、機能性セラミックスの製造方法及びカイラリティ推定方法 - Google Patents
生体応答性物質、機能性セラミックスの製造方法及びカイラリティ推定方法 Download PDFInfo
- Publication number
- JP2018008882A JP2018008882A JP2016136523A JP2016136523A JP2018008882A JP 2018008882 A JP2018008882 A JP 2018008882A JP 2016136523 A JP2016136523 A JP 2016136523A JP 2016136523 A JP2016136523 A JP 2016136523A JP 2018008882 A JP2018008882 A JP 2018008882A
- Authority
- JP
- Japan
- Prior art keywords
- substance
- ceramic
- charcoal
- human body
- bioresponsive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000126 substance Substances 0.000 title claims abstract description 51
- 239000000919 ceramic Substances 0.000 title claims description 110
- 238000000034 method Methods 0.000 title claims description 32
- 238000004519 manufacturing process Methods 0.000 title claims description 25
- 239000013078 crystal Substances 0.000 claims abstract description 111
- 230000008512 biological response Effects 0.000 claims abstract description 58
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 26
- 230000004044 response Effects 0.000 claims abstract description 26
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000010453 quartz Substances 0.000 claims abstract description 20
- 230000003993 interaction Effects 0.000 claims abstract description 7
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 claims abstract description 6
- 239000010436 fluorite Substances 0.000 claims abstract description 6
- 229910052596 spinel Inorganic materials 0.000 claims abstract description 6
- 239000011029 spinel Substances 0.000 claims abstract description 6
- 239000005332 obsidian Substances 0.000 claims abstract description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N titanium dioxide Inorganic materials O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000011017 amazonite Substances 0.000 claims abstract description 3
- 229910052586 apatite Inorganic materials 0.000 claims abstract description 3
- 239000010977 jade Substances 0.000 claims abstract description 3
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 claims abstract description 3
- 229910052594 sapphire Inorganic materials 0.000 claims abstract description 3
- 239000010980 sapphire Substances 0.000 claims abstract description 3
- 229910052877 sugilite Inorganic materials 0.000 claims abstract description 3
- 229910052613 tourmaline Inorganic materials 0.000 claims abstract description 3
- 239000011032 tourmaline Substances 0.000 claims abstract description 3
- 229940070527 tourmaline Drugs 0.000 claims abstract description 3
- 238000010304 firing Methods 0.000 claims description 48
- 239000003610 charcoal Substances 0.000 claims description 41
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 32
- 239000002994 raw material Substances 0.000 claims description 31
- 210000004556 brain Anatomy 0.000 claims description 26
- 238000012360 testing method Methods 0.000 claims description 26
- 235000012239 silicon dioxide Nutrition 0.000 claims description 24
- 229910052737 gold Inorganic materials 0.000 claims description 23
- 239000010931 gold Substances 0.000 claims description 23
- 229910010293 ceramic material Inorganic materials 0.000 claims description 21
- 239000000463 material Substances 0.000 claims description 19
- 239000011435 rock Substances 0.000 claims description 16
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims description 15
- 230000008569 process Effects 0.000 claims description 13
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 10
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 10
- 230000003287 optical effect Effects 0.000 claims description 9
- 238000010298 pulverizing process Methods 0.000 claims description 8
- 235000013162 Cocos nucifera Nutrition 0.000 claims description 7
- 244000060011 Cocos nucifera Species 0.000 claims description 7
- -1 Orbine Substances 0.000 claims description 7
- ZBKIUFWVEIBQRT-UHFFFAOYSA-N gold(1+) Chemical compound [Au+] ZBKIUFWVEIBQRT-UHFFFAOYSA-N 0.000 claims description 7
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 6
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 6
- 241001330002 Bambuseae Species 0.000 claims description 6
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 6
- 239000011425 bamboo Substances 0.000 claims description 6
- 238000003384 imaging method Methods 0.000 claims description 6
- 229910052684 Cerium Inorganic materials 0.000 claims description 5
- 229910052779 Neodymium Inorganic materials 0.000 claims description 5
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 5
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 5
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 claims description 5
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 5
- ZMIGMASIKSOYAM-UHFFFAOYSA-N cerium Chemical compound [Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce] ZMIGMASIKSOYAM-UHFFFAOYSA-N 0.000 claims description 5
- 239000011335 coal coke Substances 0.000 claims description 5
- 239000002242 colloidal glass Substances 0.000 claims description 5
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 5
- QEFYFXOXNSNQGX-UHFFFAOYSA-N neodymium atom Chemical compound [Nd] QEFYFXOXNSNQGX-UHFFFAOYSA-N 0.000 claims description 5
- 229910052763 palladium Inorganic materials 0.000 claims description 5
- 239000002006 petroleum coke Substances 0.000 claims description 5
- 229910052697 platinum Inorganic materials 0.000 claims description 5
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 claims description 5
- 150000003377 silicon compounds Chemical class 0.000 claims description 5
- 229910052709 silver Inorganic materials 0.000 claims description 5
- 239000004332 silver Substances 0.000 claims description 5
- 229910052719 titanium Inorganic materials 0.000 claims description 5
- 239000010936 titanium Substances 0.000 claims description 5
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 claims description 5
- 229910052721 tungsten Inorganic materials 0.000 claims description 5
- 239000010937 tungsten Substances 0.000 claims description 5
- 229910052727 yttrium Inorganic materials 0.000 claims description 5
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 claims description 5
- 229910052726 zirconium Inorganic materials 0.000 claims description 5
- 229910052782 aluminium Inorganic materials 0.000 claims description 4
- DVRDHUBQLOKMHZ-UHFFFAOYSA-N chalcopyrite Chemical compound [S-2].[S-2].[Fe+2].[Cu+2] DVRDHUBQLOKMHZ-UHFFFAOYSA-N 0.000 claims description 2
- 229910052951 chalcopyrite Inorganic materials 0.000 claims description 2
- 239000000835 fiber Substances 0.000 claims description 2
- 229910052710 silicon Inorganic materials 0.000 claims description 2
- 239000010703 silicon Substances 0.000 claims description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims 1
- 239000004575 stone Substances 0.000 abstract description 39
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract description 29
- 230000005291 magnetic effect Effects 0.000 abstract description 19
- 239000011521 glass Substances 0.000 abstract description 14
- 229910052742 iron Inorganic materials 0.000 abstract description 12
- 239000010975 amethyst Substances 0.000 abstract 1
- 239000002223 garnet Substances 0.000 abstract 1
- 229910052609 olivine Inorganic materials 0.000 abstract 1
- 239000010450 olivine Substances 0.000 abstract 1
- 239000011028 pyrite Substances 0.000 abstract 1
- NIFIFKQPDTWWGU-UHFFFAOYSA-N pyrite Chemical compound [Fe+2].[S-][S-] NIFIFKQPDTWWGU-UHFFFAOYSA-N 0.000 abstract 1
- 229910052683 pyrite Inorganic materials 0.000 abstract 1
- 239000011034 rock crystal Substances 0.000 abstract 1
- 239000010979 ruby Substances 0.000 abstract 1
- 229910001750 ruby Inorganic materials 0.000 abstract 1
- 238000005259 measurement Methods 0.000 description 25
- 230000017531 blood circulation Effects 0.000 description 18
- 239000000203 mixture Substances 0.000 description 16
- 230000000694 effects Effects 0.000 description 15
- 230000004913 activation Effects 0.000 description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 10
- 238000002599 functional magnetic resonance imaging Methods 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 150000002500 ions Chemical class 0.000 description 8
- 238000000465 moulding Methods 0.000 description 8
- 210000003205 muscle Anatomy 0.000 description 8
- 229910052751 metal Inorganic materials 0.000 description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000032683 aging Effects 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 239000000696 magnetic material Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 230000006641 stabilisation Effects 0.000 description 5
- 238000011105 stabilization Methods 0.000 description 5
- 230000008859 change Effects 0.000 description 4
- 239000005318 dichroic glass Substances 0.000 description 4
- 239000004579 marble Substances 0.000 description 4
- 238000000634 powder X-ray diffraction Methods 0.000 description 4
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 238000002441 X-ray diffraction Methods 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 229940043430 calcium compound Drugs 0.000 description 3
- 150000001674 calcium compounds Chemical class 0.000 description 3
- 230000003727 cerebral blood flow Effects 0.000 description 3
- 239000004927 clay Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000018044 dehydration Effects 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 210000002414 leg Anatomy 0.000 description 3
- 238000002595 magnetic resonance imaging Methods 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 239000013081 microcrystal Substances 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 230000005298 paramagnetic effect Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 2
- 229920006311 Urethane elastomer Polymers 0.000 description 2
- 238000007605 air drying Methods 0.000 description 2
- 230000005290 antiferromagnetic effect Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000007872 degassing Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 210000001624 hip Anatomy 0.000 description 2
- 239000010903 husk Substances 0.000 description 2
- 230000005389 magnetism Effects 0.000 description 2
- 229910001172 neodymium magnet Inorganic materials 0.000 description 2
- 239000002907 paramagnetic material Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 230000004043 responsiveness Effects 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 238000010583 slow cooling Methods 0.000 description 2
- 230000003313 weakening effect Effects 0.000 description 2
- 229910018125 Al-Si Inorganic materials 0.000 description 1
- 229910017090 AlO 2 Inorganic materials 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 229910018520 Al—Si Inorganic materials 0.000 description 1
- 241000233788 Arecaceae Species 0.000 description 1
- 229910004261 CaF 2 Inorganic materials 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000237503 Pectinidae Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 208000032851 Subarachnoid Hemorrhage Diseases 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 239000005407 aluminoborosilicate glass Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000000617 arm Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 230000036782 biological activation Effects 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 210000001638 cerebellum Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000002447 crystallographic data Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000000635 electron micrograph Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000010433 feldspar Substances 0.000 description 1
- 230000005293 ferrimagnetic effect Effects 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 239000010437 gem Substances 0.000 description 1
- 229910001751 gemstone Inorganic materials 0.000 description 1
- 239000010438 granite Substances 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910052892 hornblende Inorganic materials 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003434 inspiratory effect Effects 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 150000001247 metal acetylides Chemical class 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 238000013021 overheating Methods 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000020637 scallop Nutrition 0.000 description 1
- 210000001991 scapula Anatomy 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000005469 synchrotron radiation Effects 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
本実施の形態では、天然石による生体応答性を確認するため、図1に示したようなバランステストを用いた(下記非特許文献2を参照)。
表1中で生体応答が確認されている金コロイドガラスは、アルミノホウケイ酸ガラス中に金の微結晶を形成させる技術で製造された金コロイドによる茶青2色性ガラスである(特許文献1を参照)。
特許文献2で開示された機能性セラミックスの製造方法を実施する中で、製造したセラミックスを身につけて上述の天然石と同様のバランステストを試験すると強力な生体応答が確認される生体応答性のセラミックスが開発された。本実施の形態の機能性セラミックスは、特許文献2で開示された製造方法の工程に従うものである。
また、本実施の形態の製造工程において、一次焼成後のセラミックスは着磁性が顕著であり磁石に引き付けられるが、二次焼成の条件(温度と時間)によっては着磁性を失ったセラミックスも製造される。
バランステストで確認される生体応答性は、セラミックスを身に付けることで体幹の深層筋に変化が起こり、姿勢が安定するものと推定される。筋肉の活動は中枢である脳と神経系の働きで統御されているので、当該セラミックスを身に付けたときには脳の活動も活性化され、脳内血流に変化が起こることが予測される。
鉄カンラン岩系岩石を原料に使用し、機能性セラミックスの製造方法(特許文献1)により製造した機能性セラミックスの中に、身につけると強力な姿勢の安定化効果を示す生体応答性のセラミックスが開発された。古来、パワーストーンと呼ばれてきたような天然石の中には、身につけると姿勢の安定化効果を示すような石があり、原理は分からないけれどもその効果を利用する商品が市販されている。それらの天然石についてバランステストによる生体応答を調査したところ、多くの天然石が生体応答を示し、中でも、水晶の場合は右螺旋結晶構造の水晶にだけに生体応答が確認された。
Claims (16)
- 右螺旋結晶構造が形成された物質を含み、右螺旋結晶構造と人体とが相互作用することにより人体からの応答が得られる生体応答性物質。
- 前記物質は、アマゾナイト、ヒスイ、スギライト、ルチルクオーツ、天眼石、アメジスト、黄銅鉱、磁鉄鉱、フローライト、オルビン、スピネル、アパタイト、サファイア、ルビー、ガーネット、黒曜石、トルマリン、水晶、金コロイドガラスの少なくとも一つを含む請求項1に記載の生体応答性物質。
- 前記物質は、
炭及び酸化鉄を含むセラミック材料を焼成する一次焼成工程と、
前記一次焼成工程で焼成したセラミック材料をさらに700℃〜900℃の温度範囲において過熱水蒸気で焼成する二次焼成工程とを含む工程で製造された機能性セラミックスを含む請求項1に記載の生体応答性物質。 - 岩石粉砕物、ケイ酸及びアルミナを含む窯業原料、ケイ素化合物、アルミニウム化合物、貝灰の少なくとも1つから前記セラミック材料を作成する工程を含む請求項3に記載の生体応答性物質。
- 前記セラミック材料は、前記炭として、木炭、竹炭、コーヒー炭、ヤシ殻炭、石炭コークス、石油コークスの少なくとも1つを含む請求項3又は4に記載の生体応答性物質。
- 前記セラミック材料は、ジルコニウム、銀、パラジウム、金、白金、マンガン、チタン、タングステン、イットリウム、セリウム、ネオジウムの少なくとも1つを含む請求項3から5のいずれか一項に記載の生体応答性物質。
- 前記物質は、被験者が装着することにより被験者の人体からの応答が得られる請求項1から6のいずれか一項に記載の生体応答性物質。
- 前記物質は、ネックレス、ブレスレット、又は腕、足若しくは腰のサポーターに取り付けて被験者が装着する請求項7に記載の生体応答性物質。
- 前記物質は、粉砕後にシリコンやウレタンのゴム材料と複合し、インソールやサポーターに加工して被験者が装着する請求項7に記載の生体応答性物質。
- 前記物質は、粉砕後に繊維原料に錬り込み、紡糸して加工した衣類を被験者が装着する請求項7に記載の生体応答性物質。
- 機能性セラミックスの製造方法であって、炭及び酸化鉄を含むセラミック材料を焼成する一次焼成工程と、前記一次焼成工程で焼成したセラミック材料をさらに700℃〜900℃の温度範囲において過熱水蒸気で焼成する二次焼成工程とを含み、
製造された当該機能性セラミックスは、右螺旋結晶構造が形成された物質を含み、右螺旋結晶構造と人体とが相互作用することにより人体からの応答が得られる生体応答性物質を構成する機能性セラミックスの製造方法。 - 岩石粉砕物、ケイ酸及びアルミナを含む窯業原料、ケイ素化合物、アルミニウム化合物、貝灰の少なくとも1つから前記セラミック材料を作成する工程を含む請求項11に記載の機能性セラミックスの製造方法。
- 前記セラミック材料は、前記炭として、木炭、竹炭、コーヒー炭、ヤシ殻炭、石炭コークス、石油コークスの少なくとも1つを含む請求項11又は12に記載の機能性セラミックスの製造方法。
- 前記セラミック材料は、ジルコニウム、銀、パラジウム、金、白金、マンガン、チタン、タングステン、イットリウム、セリウム、ネオジウムの少なくとも1つを含む請求項11から13のいずれか一項に記載の機能性セラミックスの製造方法。
- 物質と人体とが相互作用することによる人体からの応答に基づいて前記物質に右螺旋結晶構造が含まれることを推定するカイラリティ推定方法。
- 人体からの応答は、バランステスト、光脳機能イメージング及びファンクションMRIの少なくとも1つにより測定する請求項1から15のいずれか一項に記載の生体応答性物質、機能性セラミックスの製造方法又はカイラリティ推定方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016136523A JP6859036B2 (ja) | 2016-07-11 | 2016-07-11 | 機能性セラミックス、装着物、水晶のカイラリティを推定する方法及び姿勢を安定化させる方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016136523A JP6859036B2 (ja) | 2016-07-11 | 2016-07-11 | 機能性セラミックス、装着物、水晶のカイラリティを推定する方法及び姿勢を安定化させる方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018008882A true JP2018008882A (ja) | 2018-01-18 |
JP6859036B2 JP6859036B2 (ja) | 2021-04-14 |
Family
ID=60994963
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016136523A Active JP6859036B2 (ja) | 2016-07-11 | 2016-07-11 | 機能性セラミックス、装着物、水晶のカイラリティを推定する方法及び姿勢を安定化させる方法 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6859036B2 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114105114A (zh) * | 2021-11-11 | 2022-03-01 | 上海交通大学 | 一种手性介观结构羟基磷灰石薄膜的制备方法及应用 |
CN114538398A (zh) * | 2022-02-24 | 2022-05-27 | 上海市第六人民医院 | 一种手性多级结构生物陶瓷材料及其制备方法 |
CN115099363A (zh) * | 2022-07-22 | 2022-09-23 | 核工业北京地质研究院 | 识别砂岩铀矿成矿流体作用类型的方法 |
-
2016
- 2016-07-11 JP JP2016136523A patent/JP6859036B2/ja active Active
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114105114A (zh) * | 2021-11-11 | 2022-03-01 | 上海交通大学 | 一种手性介观结构羟基磷灰石薄膜的制备方法及应用 |
CN114538398A (zh) * | 2022-02-24 | 2022-05-27 | 上海市第六人民医院 | 一种手性多级结构生物陶瓷材料及其制备方法 |
CN114538398B (zh) * | 2022-02-24 | 2024-03-15 | 上海市第六人民医院 | 一种手性多级结构生物陶瓷材料及其制备方法 |
CN115099363A (zh) * | 2022-07-22 | 2022-09-23 | 核工业北京地质研究院 | 识别砂岩铀矿成矿流体作用类型的方法 |
Also Published As
Publication number | Publication date |
---|---|
JP6859036B2 (ja) | 2021-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6859036B2 (ja) | 機能性セラミックス、装着物、水晶のカイラリティを推定する方法及び姿勢を安定化させる方法 | |
Bretcanu et al. | Magnetic properties of the ferrimagnetic glass-ceramics for hyperthermia | |
Singh et al. | Iron doped β-Tricalcium phosphate: Synthesis, characterization, hyperthermia effect, biocompatibility and mechanical evaluation | |
Leventouri et al. | Structure, microstructure, and magnetism in ferrimagnetic bioceramics | |
CN101774672B (zh) | 一种用于制备多功能健康活水的功能材料及其制造方法 | |
Kawashita et al. | Preparation of ceramic microspheres for in situ radiotherapy of deep-seated cancer | |
KR101172495B1 (ko) | 가공된 초상자성 마그네시움 페라이트 나노입자의 제조방법 | |
Li et al. | A novel method to enhance magnetic property of bioactive glass-ceramics for hyperthermia | |
KR100768496B1 (ko) | 복합재 및 그의 제조방법과, 그것에 사용되는 복합재료 | |
CN104605684B (zh) | 一种便携型磁疗睡垫 | |
Khizroev et al. | Engineering future medicines with magnetoelectric nanoparticles: Wirelessly controlled, targeted therapies | |
Dacheux et al. | Characterization of the thorium phosphate-hydrogenphosphate hydrate (TPHPH) and study of its transformation into the thorium phosphate-diphosphate (β-TPD) | |
CN102935056B (zh) | 一种矿泥隔离霜及其制备方法 | |
CN100360687C (zh) | 一种具有磁性保健功能的皮革材料及其应用 | |
VARMA et al. | Preparation and characterization of free flowing hydroxy apatite powders | |
Vlasova et al. | Mechanosynthesis of hydroxyapatite–ferrite composite nanopowder | |
US20090181844A1 (en) | Ceramic Material | |
Wang et al. | Evaluating the effects of chemical composition on induction heating ability of Fe2O3‐CaO‐SiO2 glass ceramics | |
CN104278543B (zh) | 一种包括负离子颗粒的染料 | |
EA009095B1 (ru) | Магнитоуправляемый сорбент и способ его получения | |
CN102174507A (zh) | 一种杀灭肿瘤细胞的方法和系统 | |
KR101777112B1 (ko) | 마그마 화산석과 음이온 분말로부터 제조되는 액세서리 및 그의 제조 방법 | |
CN105600905A (zh) | 一种负离子富氢水的制备方法 | |
CN110833796A (zh) | 一种具有促眠功能的新材料复合颗粒及其制备方法 | |
Pyatakov et al. | Short history overview of magnetism and magnetic technologies for medical applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190220 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200114 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20200312 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200413 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200728 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200918 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210126 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210212 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210316 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210325 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6859036 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313117 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |